Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Bergmann

Showing results (171-180 of 254) with videos related to

Pageof 26
Sort By:
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|February 23, 2018
Proenkephalin and risk of developing chronic kidney disease: the Prevention of Renal and Vascular End-stage Disease studyLyanne M Kieneker, Oliver Hartmann, Andreas Bergmann, et al.
Plos One|April 28, 2015
In Vivo Volatile Organic Compound Signatures of Mycobacterium avium subsp. paratuberculosisAndreas Bergmann, Phillip Trefz, Sina Fischer, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 27, 2009
Trim24 targets endogenous p53 for degradationKendra Allton, Abhinav K Jain, Hans-Martin Herz, et al.
JAMA|October 11, 2012
Plasma proneurotensin and incidence of diabetes, cardiovascular disease, breast cancer, and mortalityOlle Melander, Alan S Maisel, Peter Almgren, et al.
Biological Psychiatry|April 12, 2005
Decreased serum amyloid beta(1-42) autoantibody levels in Alzheimer's disease, determined by a newly developed immuno-precipitation assay with radiolabeled amyloid beta(1-42) peptideSylvia Brettschneider, Nils G Morgenthaler, Stefan J Teipel, et al.
The American Journal of Emergency Medicine|November 19, 2015
Plasma bioactive adrenomedullin as a prognostic biomarker in acute heart failureWesley H Self, Alan B Storrow, Oliver Hartmann, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 14, 2014
Validation of plasma proneurotensin as a novel biomarker for the prediction of incident breast cancerOlle Melander, Mattias Belting, Jonas Manjer, et al.
Journal of Cardiac Failure|February 16, 2024
Low Levels of Selenoprotein P Are Associated With Cognitive Impairment in Patients Hospitalized for Heart FailureAmra Jujić, John Molvin, Erik D Nilsson, et al.
American Journal of Hypertension|July 17, 2010
Plasma C-terminal pro-endothelin-1 is associated with target-organ damage in African Americans with hypertensionAmmar Habib, Malik A Al-Omari, Mahyar Khaleghi, et al.
The Journal of Clinical Psychiatry|January 7, 2011
Prediction of Alzheimer's disease using midregional proadrenomedullin and midregional proatrial natriuretic peptide: a retrospective analysis of 134 patients with mild cognitive impairmentKatharina Buerger, Olga Uspenskaya, Oliver Hartmann, et al.
Pageof 26

Showing results (171-180 of 254) with videos related to

Sort By:
Pageof 26
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|February 23, 2018
Proenkephalin and risk of developing chronic kidney disease: the Prevention of Renal and Vascular End-stage Disease studyLyanne M Kieneker, Oliver Hartmann, Andreas Bergmann, et al.
Plos One|April 28, 2015
In Vivo Volatile Organic Compound Signatures of Mycobacterium avium subsp. paratuberculosisAndreas Bergmann, Phillip Trefz, Sina Fischer, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 27, 2009
Trim24 targets endogenous p53 for degradationKendra Allton, Abhinav K Jain, Hans-Martin Herz, et al.
JAMA|October 11, 2012
Plasma proneurotensin and incidence of diabetes, cardiovascular disease, breast cancer, and mortalityOlle Melander, Alan S Maisel, Peter Almgren, et al.
Biological Psychiatry|April 12, 2005
Decreased serum amyloid beta(1-42) autoantibody levels in Alzheimer's disease, determined by a newly developed immuno-precipitation assay with radiolabeled amyloid beta(1-42) peptideSylvia Brettschneider, Nils G Morgenthaler, Stefan J Teipel, et al.
The American Journal of Emergency Medicine|November 19, 2015
Plasma bioactive adrenomedullin as a prognostic biomarker in acute heart failureWesley H Self, Alan B Storrow, Oliver Hartmann, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 14, 2014
Validation of plasma proneurotensin as a novel biomarker for the prediction of incident breast cancerOlle Melander, Mattias Belting, Jonas Manjer, et al.
Journal of Cardiac Failure|February 16, 2024
Low Levels of Selenoprotein P Are Associated With Cognitive Impairment in Patients Hospitalized for Heart FailureAmra Jujić, John Molvin, Erik D Nilsson, et al.
American Journal of Hypertension|July 17, 2010
Plasma C-terminal pro-endothelin-1 is associated with target-organ damage in African Americans with hypertensionAmmar Habib, Malik A Al-Omari, Mahyar Khaleghi, et al.
The Journal of Clinical Psychiatry|January 7, 2011
Prediction of Alzheimer's disease using midregional proadrenomedullin and midregional proatrial natriuretic peptide: a retrospective analysis of 134 patients with mild cognitive impairmentKatharina Buerger, Olga Uspenskaya, Oliver Hartmann, et al.
Pageof 26